98%
921
2 minutes
20
Objective: Achieving age-specific goals is a central aspect of adolescent development. Adolescents with epilepsy have obstacles in their daily lives which might make it difficult for them to achieve their goals. To date, only a few studies have investigated this issue for a wide range of goals.
Methods: We surveyed 363 German adolescents with and without epilepsy using a cross-sectional design.
Results: Adolescents with epilepsy reported higher success in one developmental goal (socially responsible behaviour) and less success in social goals (belonging to a peer group and forming romantic relationships) and achieving gender role identity compared with adolescents without chronic diseases. Furthermore, perceived goal attainment did not vary by type of epilepsy. Finally, perceived attainment of goals in adolescents with epilepsy varied, in part, between those who were medication-free and those who were not.
Discussion: The Results indicate that adolescents with epilepsy need support in building social relationships with their peers. Specific treatment recommendations may be provided based on these results.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.yebeh.2025.110558 | DOI Listing |
Epilepsy Res
September 2025
Division of Pediatric Neurology, Developmental Medicine and Social Pediatrics Department of Pediatrics, Dr. von Hauner Children's Hospital, Ludwig-Maximilians-University, Lindwurmstrasse 4, Munich 80337, Germany; Comprehensive Epilepsy Center, Ludwig-Maximilians-University, Munich, Germany. Electron
Background: The EpiTrack Junior is a screening tool assessing executive function in children with epilepsy. This study aimed to investigate whether children and adolescents with epilepsy are at a higher risk of experiencing a reduced quality of life if they also reveal abnormal results reflecting executive dysfunction.
Methods: We screened patients for executive dysfunction using the clinical test tool EpiTrack Junior.
Neurology
October 2025
Neurology, Epilepsy and Movement Disorders Unit, Bambino Gesù Children's Hospital, IRCCS, Full Member of European Reference Network on Rare and Complex Epilepsies - EpiCARE, Rome, Italy.
Objectives: Neuronal ceroid lipofuscinosis type 3 (CLN3) is a rare lysosomal storage disorder characterized by progressive neurodegeneration. No disease-modifying treatments are currently available. Miglustat, a substrate reduction therapy, has shown preclinical efficacy in CLN3 models (conference abstract).
View Article and Find Full Text PDFNeurology
October 2025
Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD.
Objectives: Status epilepticus (SE) is a life-threatening neurologic emergency. Although health disparities in epilepsy are well-documented, disparities in SE mortality are not fully understood. This study analyzes mortality trends and demographics in the United States from 1999 through 2020.
View Article and Find Full Text PDFJ Infect Dev Ctries
August 2025
Department of Infectious Diseases and Clinical Microbiology, Health Sciences University Adana City Training and Research Hospital, Adana, Turkey.
Introduction: To evaluate the characteristics of patients who have undergone surgical operations due to brain abscess and to assess the risk factors for mortality and the outcomes.
Methodology: Patients who have undergone surgical operations due to brain abscess between January 2014 and January 2024 in our hospital were evaluated retrospectively. Patients were divided into 2 groups to determine poor outcome predictive factors.
Neurochirurgie
September 2025
Necker Hospital, Departments of Pediatric Neurosurgery, Radiology, Pediatric Neurology and Anesthesiology; Reference Center for Rare Epilepsies CRéER, Member of ERN Epicare; APHP, Paris, France; Université de Paris Cité, Paris, France; Institut Imagine, INSERM U1163, Paris, France; Paris Kids Can
Introduction: Laser Interstitial Thermal Therapy under MRI control has emerged as a safe and efficient alternative to microsurgery in epilepsy and neurooncology procedures. Yet it has been used only recently in seldom European centers. Here, we report our 4 years' experience with LITT in children (complications, epileptic and oncologic outcomes).
View Article and Find Full Text PDF